Retatrutidesometimes called Reta, or informally GLP-3is the next evolution in a class of weight loss drugs known as GLP-1 receptor agonists
They compared 12,004 records of patients on a GLP-1 receptor agonist, like semaglutide or tirzepatide, to 15,221 using SGLT-2 drugs and 11,964 GLP-1 drug patients to 11,238 people taking DPP-4 inhibitors
Lab work is required for starting Growth Hormone Stimulation or Peptide Therapy
These medications are delivered subcutaneously, which means they work best when injected into fatty tissue
Glucagon-like peptide-1 (GLP-1) is a naturally occurring hormone produced in the intestinal L-cells of the human gastrointestinal tract
And another study from George Washington University found that people on GLP-1 medications had a higher risk of experiencing hair loss